Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.85
+0.75 (1.97%)
Feb 11, 2026, 1:23 PM CST
Market Cap2.78B -21.5%
Revenue (ttm)n/a
Net Income-141.91M
EPS-1.99
Shares Out71.32M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,260
Average Volume50,375
Open38.85
Previous Close38.10
Day's Range38.50 - 38.95
52-Week Range33.30 - 59.40
Beta-0.22
RSI54.97
Earnings DateNov 14, 2025

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase IIa clinical trial and SNP-630 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan. It is also developing SNP-810 is in phase II clinical trial for use in pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for ac... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 48
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements